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Abstract
Background: The Berlin Fat Mouse Inbred (BFMI) line is a new mouse model for obesity, which was long-term
selected for high fatness. Peroxisome proliferator-activated receptors (PPARs) are involved in the control of energy
homeostasis, nutrient metabolism and cell proliferation. Here, we studied the expression patterns of the different
Ppar genes and the genes in the PPAR pathway in the BFMI line in comparison to physiological changes.
Results: At the age of 10 weeks, the BFMI mice exhibited marked obesity with enlarged adipocytes and high
serum triglycerides concentrations in comparison to the often used mouse line C57BL/6 (B6). Between these two
lines, gene expression analyses revealed differentially expressed genes belonging to the PPAR pathway, in
particular genes of the lipogenesis and the fatty acid transport.
Conclusion: Surprisingly, the Ppar-a gene expression was up-regulated in liver and Ppar-g gene expression was
down-regulated in the white adipose tissue, indicating the activation of a mechanism that counteracts the rise of
obesity.
Background
The peroxisome proliferator-activated receptors (PPARs)
constitute a family of three genes, which are involved in
the control of energy homeostasis and cell proliferation.
The PPAR family members have distinct patterns of tis-
sue distribution and tissue specific functions. PPAR-a is
predominantly present in liver where it has a critical
role in the regulation of nutrient metabolism as it sti-
mulates the uptake and oxidation of fatty acids. PPAR-g
is mainly expressed in adipose tissue. It is induced dur-
ing adipocyte differentiation and is a regulator in the
formation of fat cells and lipid accumulation. PPAR-δ is
abundantly expressed throughout the body and it has
been proposed to be involved in adipogenesis and
energy metabolism [for review, see [1-3]]. Activation of
PPAR-a by agonists leads to reduced adiposity and
lowered triglyceride levels by reduced food intake [4-6],
whereas activation of PPAR-g by agonist stimulates lipid
storage and is associated with body weight gain [7,8].
Recently, we have generated the high-fatness selected
Berlin Fat Mouse inbred line BFMI as a model for juve-
nile obesity [9]. BFMI mice harbour natural mutations
leading to a five fold increased fat percentage due to
hyperphagia at young age and an altered lipid metabo-
lism in comparison to C57BL/6 mice [10,11]. A specific
regulation of PPAR genes in the development of obesity
in the BFMI mice is very likely.
Therefore, the intention of this study was to investi-
gate whether the Ppars and their responsive genes are
involved in the fat accumulation of the BFMI line. Our
aims were (i) to identify differences in gene regulation
of Ppars and their responsive genes between the obese
BFMI mouse model and B6 mice as a control and (ii) to
analyze responses of PPAR pathway genes to high-fat
diet feeding in BFMI mice. Therefore, we analysed tran-
script amounts of genes belonging to the PPAR pathway
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lysed body composition, adipocyte size and serum
parameters.
Results
Phenotypic differences between lines BFMI and B6
To compare the body composition of the two lines,
male mice of BFMI and B6 were fed a standard mainte-
nance diet (SMD) until week 10. On SMD, animals of
t h eB F M Il i n ew e r es i g n i f i c a n t l yh e a v i e ra n dh a dm o r e
body fat and lean mass than B6 mice over the entire
period (Figure 1). At 10 weeks, mice of the BFMI line
were 1.8 times as heavy as B6 mice (41.4 ± 2.9 g and
23.5 ± 1.5 g, respectively). The body weight gain was
due to increased fat mass. BFMI mice had almost 10
times as much body fat mass but only 1.5 times as
much lean mass as B6 animals. In BFMI mice, fat was
accumulated in all three investigated adipose tissues
mainly due to enlarged adipocytes (Table 1, Figure 2
and 3). The weight of the liver was slightly higher in10
weeks old BFMI mice compared to B6 mice which
could be due to increased fat accumulation in liver of
BFMI mice (Table 1, Figure 3). Serum triglyceride con-
centrations, but not total cholesterol concentrations,
were elevated in BFMI mice compared to B6.
Feeding of HFD in mice of the BFMI line caused an
additional body weight and body fat mass gain (9.0 g
and 6.4 g, respectively). The excess amount of white adi-
pose tissue (WAT) was more pronounced in subcuta-
neous and renal adipose tissue than in the reproductive
adipose tissues (Table 1). This is in accordance with the
observation that subcutaneous white adipose tissue is
known as a primary fat storage depot. However, adipo-
cytes were only slightly increased in subcutaneous adi-
pose and not further increased in reproductive and
renal adipose tissue indicating that proliferation of adi-
pocytes occurs to uptake the additional fat in HFD-fed
BMFI mice (Figure 2). Liver weight was significantly
increased in mice on HFD due to increased fat accumu-
lation (Figure 3). Serum triglyceride concentrations were
not further increased in BFMI mice on HFD, but serum
total cholesterol concentrations were elevated (Table 1).
Comparison of genes belonging to the PPAR pathway
between BFMI and B6 mice
Among the members of the PPAR signalling pathway
(KEGG database), 20 and 19 genes were differentially
expressed between the lines BFMI and B6 on SMD in
adipose tissue and in liver, respectively (Table 2,
Figure 4).
On SMD, the transcript amount of Ppar-a, Ppar-g and
their receptors Rxra and Rxrg in reproductive adipose
tissue were lower in BFMI mice compared to B6. Corre-
spondingly, down-stream activated genes of the fatty
acid oxidation but also genes of the lipogenesis were
down-regulated. Within the fatty acid oxidation path-
way, members of the cytochrome family, the acetyl-CoA
acyltransferase (Acaa1) and the carnitine palmitoyltrans-
ferase 2 (Cpt2) were decreased. Lipogenesis in BFMI
Figure 1 Comparisons of lines BFMI and B6 on standard
maintenance diet (SMD) and of line BFMI on high-fat diet
(HFD). Body weight, body fat mass and body lean mass from three
to 10 weeks of age. Lines differ from 3 weeks of age on and
animals between the two diet groups differ from 4 weeks of age in
line BFMI (P < 0.05). Each point represents the mean weight with
standard deviation.
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enzyme (Mod1), which provides energy rich molecules
for the fatty acid synthesis.
Transcript amounts of genes encoding phospholipid
transfer protein (Pltp), Cd36 antigen, fatty acid binding
protein (Fabp3) and Acyl-CoA-synthetase (Acsl4), which
are responsible for lipid and fatty acid transport, were up-
regulated in BFMI mice compared to B6. The uncoupling
protein 1 (Ucp1) that enhances thermogenesis was also
highly up-regulated in reproductive adipose tissue in
BFMI mice.
Unlike in adipose tissue, the expression of Ppar-a and
its receptors Rxra and Rxrg were increased in liver. As
in adipose tissue, genes of the lipid or fatty acid trans-
port (here Apoa2, Apoa5 and Fabp3)w e r em o r e
expressed in liver of BFMI mice than in B6 mice. Genes
involved in fatty acid oxidation were differentially
expressed between both mouse lines. Liver transcript
amounts of Acyl-CoA oxidase (Acox2) and acyl-Coen-
zyme A dehydrogenase (Acadm) were higher, whereas
3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh),
Cpt2 and members of the cytochrome P450 family were
lower in BFMI than in B6.
Diet effect on genes of the PPAR pathway in BFMI mice
To determine whether dietary fat regulates the expres-
sion of genes of the PPAR pathway in BFMI mice,
mRNA expression profiles of reproductive adipose tissue
and liver of mice on SMD and HFD were compared. In
response to HFD, the mRNA expression of Ppar-g and
its receptor was down-regulated in reproductive adipose
tissue, whereas the expression of Ppar-a and its receptor
were reduced in liver. Transcriptional response in both
tissues indicated that most genes involved in lipid meta-
bolism were up-regulated (Table 2, Figure 4). An excep-
tion was the cholesterol metabolism, which was
reduced. In particular, genes involved in lipogenesis
(Scd1, Mod1) but also in peroxisomal and mitochondrial
fatty acid oxidation (Acaa1, Cpt2)a n di nk e t o g e n e s i s
(Hmgcs2) were up-regulated in response to HFD.
In addition, the expression of genes of the fatty acid
transport (Acsl4, Dbi, Fabp3) and of the cell survival
(Pdpk1) were increased in reproductive adipose tissue.
The Ucp1 expression was further elevated in line BFMI.
Genes affecting adipocyte differentiation, like angiopoie-
tin-like 4 (Angptl4), which is involved in the cellular
response to starvation, and adiponectin were down-
regulated in this tissue in response to HFD-feeding. In
liver tissue, genes belonging to lipid transport (Apoa1,
Apoa3) were further up-regulated.
Discussion
The BFMI line is a model for studies of obesity and subse-
quent complications, which are close to obese humans.
T h ep u r p o s eo ft h ep r e s e n t e dw o r kw a st oe v a l u a t et h e
role of different Ppar genes and their responsive genes in
the fat accumulation in the BFMI mice as PPARs are
important regulators of lipid metabolism and energy
homeostasis. Increased fat accumulation accompanied
with increased adipocyte size and elevated serum triglycer-
ide levels, observed in BFMI compared to B6 mice in this
study, makes a change of Ppar gene expression and their
responsive genes very likely. As PPAR-a agonists lead to
Table 1 Body composition and serum parameters in 10
week old BFMI and B6 mice on SMD and BFMI mice on
HFD
Trait B6 BFMI on
SMD
BFMI on
HFD
Body weight (g) 23.4 (1.4) 39.2 (2.7)* 47.8 (2.3)+
Body composition traits
Body lean mass (g) 19.97
(0.95)
29.29 (1.71)* 31.43 (1.38)+
Body fat mass (g) 0.97 (0.31) 8.84 (2.26)* 14.56 (2.26)+
Total white fat tissue (g) 1.11 (0.26) 7.70 (1.70)* 12.10 (0.95)+
Reproductive fat pad (g) 0.23 (0.05) 1.96 (0.43)* 2.26 (0.53)
Renal fat pad (g) 0.07 (0.03) 0.69 (0.13)* 1.01 (0.19)+
Subcutaneous fat pad (g) 0.50 (0.15) 2.57 (1.02)* 4.42 (1.42)+
Liver (g) 1.16 (0.15) 2.19 (0.22)* 3.33 (0.46)+
Serum parameter traits
Triglycerides (mg/dl) 123 (63) 277 (95)* 245 (97)
Total cholesterol (mg/dl) 103 (20) 100 (11) 177 (24)+
SMD, standard maintenance diet; HFD, high-fat diet; values represent mean
values with standard deviation in parenthesis of B6 on SMD (n = 15), BFMI on
SMD (n = 11), and BFMI on HFD (n = 12). Serum parameters were obtained
after a fasting period of two hours (BFMI on SMD (n = 8), BFMI on HFD
(n = 8), and B6 (n = 12)). Asterisks indicate significant differences between
BFMI860 and B6. Except for cholesterol all values were significantly different
between B6 and BFMI mice on SMD. + indicates significant differences
between standard maintenance and high-fat diet within line BFMI860
(P < 0.05).
Figure 2 Adipocyte diameter of reproductive (RPF),
retroperitoneal (RF), and inguinal (IF) adipose tissue of B6 and
BFMI mice on standard maintenance diet (SMD) and of BFMI
mice on high-fat diet (HFD). Animals were 10 weeks old.
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lipid storage and body weight gain [7,8] we would have
expected a down-regulation of Ppar-a in liver and an up-
regulation of Ppar-g in adipose tissue in BFMI mice com-
pared to B6. In contrast to our expectation, transcript
amounts in white adipose tissue and in liver revealed a
down-regulation of Ppar-a and Ppar-g and their receptors
in adipose tissue and an up-regulation of Ppar-a and its
receptor in liver in the high-fatness selected BFMI line
compared to B6. In response to HFD, BFMI mice showed
af u r t h e rr e d u c t i o no fPpar-g and Rxrg mRNA levels in
adipose tissue but a reduced mRNA level of Ppar-a and
its receptor in liver.
The observation that Ppar-a mRNA levels are
increased in liver of BFMI mice compared to B6 corre-
sponds well with findings in ob/ob and db/db mice in
comparison with lean mice [12]. But this is in contrast
with findings in Ppar-a deficient mice which had higher
fat mass, liver weight and triglyceride concentrations
[13,14]. In obese mice, PPAR-a might be activated to
Figure 3 Hematoxylin and eosin stained section of reproductive (RPF), retroperitoneal (RF), and inguinal (IF) adipose tissue and oil-red
staining of liver sections of B6 and BFMI mice on standard maintenance diet (SMD) and of BFMI mice on high-fat diet (HFD) at 10
weeks.
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Page 4 of 10Table 2 Changes in expression of genes involved in the PPAR pathway.
Gene symbol BFMI860/B6 (SMD) HFD/SMD (BFMI860)
Entrez Gene-IDs Fat liver fat liver
Fold ch. p-value Fold ch. p-value Fold ch. p-value Fold ch. p-value
PPAR isoforms and receptors
19013 Ppara 0.87 < 0.01 2.67 < 0.01 0.95 ns 0.48 < 0.01
19015 Ppard 1.07 ns 0.98 ns 0.73 ns 0.88 ns
19016 Pparg 0.66 < 0.01 0.83 < 0.05 0.70 < 0.01 0.96 ns
20181 Rxra 0.69 < 0.01 1.09 < 0.05 0.95 ns 0.89 < 0.05
20182 Rxrb 0.98 ns 1.06 ns 1.00 ns 1.00 ns
20183 Rxrg 0.84 < 0.01 1.29 < 0.01 0.81 < 0.01 1.02 ns
Lipid transport
11806 Apoa1 0.97 ns 0.96 ns 1.04 ns 1.11 < 0.01
11807 Apoa2 0.97 ns 1.21 < 0.05 1.16 ns 1.02 ns
66113 Apoa5 0.94 ns 1.32 < 0.05 1.00 ns 0.92 ns
11814 Apoc3 0.98 ns 0.94 ns 0.98 ns 1.15 < 0.01
18830 PLTP 2.32 < 0.01 0.75 ns 0.64 ns 1.26 ns
Fatty acid transport
14081 Acsl1 0.97 ns 0.97 ns 0.82 ns 0.84 ns
74205 Acsl3 1.03 ns 1.01 ns 0.98 ns 0.94 ns
50790 Acsl4 1.14 < 0.05 0.98 ns 1.18 < 0.05 1.03 ns
433256 Acsl5 1.09 ns 1.02 ns 1.05 ns 1.12 ns
216739 Acsl6 0.97 ns 0.99 ns 1.01 ns 1.06 ns
12491 Cd36 1.61 < 0.01 1.06 ns 1.16 ns 1.42 < 0.05
13167 Dbi 0.86 ns 0.92 ns 1.39 < 0.01 1.08 ns
14080 Fabp1 1.09 ns 1.04 ns 0.97 ns 0.87 < 0.05
14079 Fabp2 1.05 ns 1.08 ns 0.95 ns 0.85 < 0.01
14077 Fabp3 1.36 < 0.05 1.15 < 0.05 1.83 < 0.01 0.90 ns
11770 Fabp4 1.00 ns 1.01 ns 1.26 ns 0.95 ns
16592 Fabp5 1.47 ns 0.88 ns 1.38 ns 0.99 ns
16204 Fabp6 0.94 < 0.01 1.02 ns 1.02 ns 1.04 ns
12140 Fabp7 1.07 ns 0.96 ns 0.97 ns 0.96 ns
16956 Lpl 0.85 < 0.01 1.02 ns 1.04 ns 0.95 ns
108078 Olr1 0.96 ns 1.01 ns 0.99 ns 0.95 ns
26457 Slc27a1 0.75 ns 0.97 ns 0.99 ns 1.03 ns
26458 Slc27a2 1.02 ns 0.97 ns 0.97 ns 1.15 ns
26569 Slc27a4 1.07 ns 1.01 ns 0.92 < 0.05 0.99 ns
26459 Slc27a5 0.99 ns 1.06 ns 1.00 ns 0.83 < 0.01
225579 Slc27a6 1.14 < 0.01 0.82 < 0.01 0.96 ns 1.11 < 0.05
Fatty acid oxidation
113868 Acaa1a 0.78 < 0.05 0.97 ns 1.46 < 0.05 1.15 < 0.05
11363 Acadl 0.91 ns 1.1 ns 1.09 ns 1.18 ns
11364 Acadm 0.7 ns 1.89 < 0.01 0.93 ns 1.08 ns
11430 Acox1 1.07 ns 1.74 ns 1.06 ns 0.67 ns
93732 Acox2 1.05 ns 1.76 < 0.01 0.97 ns 0.80 ns
80911 Acox3 0.99 ns 1.01 ns 0.99 ns 0.99 ns
12894 Cpt1a 0.98 ns 1.01 ns 0.99 ns 0.94 ns
12895 Cpt1b 1.17 ns 0.99 ns 1.20 < 0.05 1.07 ns
78070 Cpt1c 0.96 ns 1.01 ns 0.97 ns 0.98 < 0.05
12896 Cpt2 0.71 < 0.01 0.63 < 0.01 1.61 < 0.05 1.85 < 0.01
13117 Cyp4A10 1.00 ns 0.24 < 0.01 0.98 ns 5.07 < 0.01
13118 Cyp4a12b 1.03 ns 0.80 ns 0.94 ns 0.59 < 0.05
13119 Cyp4a14 0.90 < 0.01 0.06 < 0.01 1.06 ns 31.29 < 0.01
74147 Ehhadh 0.98 ns 0.69 < 0.05 0.89 ns 2.17 < 0.01
20280 Scp2 0.85 ns 0.95 ns 0.87 ns 0.91 ns
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sive genes involved in lipid transport are up-regulated,
but despite the up-regulation of PPAR-a expression
genes involved in fatty acid oxidation are down-regu-
lated, which leads to fat accumulation in the liver. The
accumulation of fat in the liver suggests preferred usage
of glucose for oxidation, which is consistent with higher
respiratory quotients in BFMI mice [10].
BFMI mice responded to HFD by a reduction of
PPAR-a expression in liver. This is in line with
increased adiposity in Ppar-a null mice after HFD-feed-
ing [4]. Our finding is in contrast with the increased
PPAR-a expression in diet-induced obese B6 mice, in
which it goes along with elevated fatty acid oxidation
[14]. In BFMI mice, genes of lipid transport, lipogenesis,
fatty acid oxidation and ketogenesis were up-regulated
despite the reduced Ppar expression. This finding sug-
gests hat the PPAR-a signalling in BFMI mice might be
disturbed or that other factors have a stronger influence
on lipid metabolism. Despite elevated fatty acid utiliza-
tion in the liver the high lipid storage resulted in a fatty
liver in HFD-fed BFMI mice.
PPAR-g activation is essential for the formation of adi-
pocytes and, as a consequence, Ppar-g knockout mice
fail to develop adipose tissue [7,8]. In db/db and ob/ob
mice PPAR-g agonism or activation led to the reduction
of serum concentrations of triglycerides [5,15]. Surpris-
ingly, in BFMI mice Ppar-g is down-regulated despite
high body fat mass and increased adipocyte size in com-
parison to B6. In the white adipose tissue, the decreased
Table 2: Changes in expression of genes involved in the PPAR pathway. (Continued)
Ketogenesis
15360 Hmgcs2 0.92 ns 1.27 ns 1.72 < 0.01 1.14 < 0.05
Lipogenesis
56473 Fads2 1.05 ns 0.69 ns 0.93 ns 3.16 < 0.01
677317 Mod1 0.58 < 0.01 0.75 ns 2.26 < 0.01 2.81 < 0.01
20249 Scd1 0.76 < 0.01 0.81 < 0.05 1.45 < 0.01 1.33 < 0.01
20250 Scd2 1.26 ns 1.46 < 0.01 2.03 < 0.01 1.16 ns
30049 Scd3 1.03 ns 0.98 ns 0.98 ns 1.02 ns
329065 Scd4 1.01 ns 1.06 ns 0.98 ns 1.00 ns
Cholesterol metabolism
104086 Cyp27a1 1.04 ns 1.00 ns 0.78 < 0.01 0.70 < 0.01
13122 Cyp7a1 0.96 ns 2.31 ns 1.00 ns 0.49 ns
13124 Cyp8b1 1.00 ns 1.37 < 0.05 0.99 ns 1.04 ns
22259 Nr1h3 0.96 ns 0.92 ns 0.76 < 0.05 1.11 ns
Gluconeogenesis
11832 Aqp7 0.83 ns 1.04 ns 1.12 ns 1.03 ns
14626 Gk2 1.02 ns 1.01 ns 1.05 ns 1.03 ns
14933 Gyk 1.01 ns 0.96 ns 1.00 ns 1.00 ns
18534 Pck1 0.65 ns 0.54 ns 0.87 ns 1.15 ns
74551 Pck2 0.99 ns 1.17 < 0.01 0.97 ns 0.86 < 0.05
Adipocyte differentiation
11450 Adipoq 0.71 < 0.05 0.97 ns 0.49 < 0.01 1.01 ns
57875 Angptl4 1.41 ns 0.84 ns 0.71 < 0.01 1.04 ns
83995 Mmp1a 1.02 ns 0.99 ns 0.99 ns 1.00 ns
83996 Mmp1b 1.06 ns 0.97 ns 0.97 ns 1.04 ns
103968 Plin 0.70 ns 0.98 ns 0.68 ns 1.03 ns
20411 Sorbs1 0.95 ns 0.94 ns 1.04 ns 1.06 ns
Adaptive thermogenesis
22227 Ucp1 2.65 < 0.01 1.03 ns 2.87 < 0.01 0.98 ns
Cell survival
16202 Ilk 1.27 ns 0.83 ns 0.77 ns 1.14 < 0.05
18607 Pdpk1 0.62 < 0.01 1.38 < 0.01 1.61 < 0.05 0.83 < 0.05
Ubiquitination
22190 Ubc 0.87 ns 1.25 ns 0.83 ns 0.76 ns
Changes in expression are expressed as fold changes in BFMI860 in comparison to B6 mice on SMD, and of HFD-fed BFMI860 mice compared to SMD-fed mice,
respectively. SMD- standard maintenance diet, HFD- high-fat diet, ns-not significant
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decreased fatty acid oxidation. This coincides with the
observation in Zucker rats, in which PPAR-g agonism
led to stimulation of genes involved in fatty acid oxida-
tion [16]. In BFMI mice, reduction of fatty acid oxida-
tion might be also due to the interaction with Ppar-a,
which is also lowered in adipose tissue. Reduced fatty
acid oxidation and elevated fatty acid transport in BFMI
mice compared to B6 lead to an elevated fat deposition
and increased white adipose tissues with hypertrophic
adipocytes in BFMI mice. As the proportion of the adi-
pose tissue weights between BFMI and B6 mice was lar-
ger than the proportion of the adipocyte size between
the lines, we suggest that proliferation of adipocytes still
occurs in BFMI mice.
However, there were also fat storage counteracting
effects in BFMI mice. The expression of Ucp1,w h i c h
facilitates thermogenesis, was highly increased in line
BFMI in comparison to B6. UCPs could dispose excess
energy by uncoupling mitochondrial respiration from
oxidative phosphorylation under fatty acid consumption
[17]. In response to HFD, Ucp1 as well as genes of the
fatty acid oxidation (Acaa1a, Cpt1b, Cpt2) were further
elevated in adipose tissue of BFMI mice. Moreover, in
adipose tissue and liver of BFMI mice on HFD, fatty
acids seem to be converted to ketones as energy sources.
The high amount of Ucp1 transcripts and the change of
fatty acid utilisation indicate a counteraction to the
excessive energy supply and might explain the
unchanged triglyceride levels in BFMI mice on SMD
and HFD. An up-regulation of Ucp1 in response to
HFD was also seen in DBA/2J mice [18]. The increase
in fat mass in HFD-fed mice mirrors further lipid sto-
rage as a result of fatty acid uptake and lipogenesis
which were up-regulated. As the adipocyte size was not
further increased, but tissue mass nearly doubled in
HFD-fed BFMI mice compared to SMD, cell prolifera-
tion still takes place, thus developing additional adipo-
cytes. This is indicated by an up-regulation of Pdpk1,
which is involved in cell survival. Surprisingly, new adi-
pocytes are developed in BFMI mice despite the
decreased Ppar-g expression in response to HFD. This is
in contrast with findings in heterozygous Ppar-g mutant
mice that had smaller fat pads [19]. In BFMI mice,
down-regulation of Ppar-g expression seems to counter-
act fat accumulation rather than to promote fat storage.
Figure 4 Differentially expressed genes of the of Ppar pathway genes between BFMI and B6 on standard maintenance diet (SMD) (A)
in reproductive adipose tissue (A) and liver (B) and between SMD- and high-fat diet (HFD)-fed BFMI mice in reproductive adipose
tissue (C) and liver (D). The PPAR pathway is according to KEGG, visualisation was done with GenMapp.
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but little is known about its role in lipid metabolism [2].
Although it seems to play a role in obesity [20], Ppar-δ
expressions of reproductive adipose tissue and liver
were similar in BFMI and B6 mice. Furthermore, they
w e r en o tc h a n g e db yt h ed i e t .T h es a m ew a sf o u n di n
liver of ob/ob and db/db mice in comparison to B6 [12].
In summary, elevated fatty acid and lipid transport
into adipose tissue accompanied by lower fatty acid oxi-
dation contribute to hypertrophy of adipocytes and
excess of body fat mass in the high-fatness selected
BFMI line. Our results suggest that the regulation of
Ppar genes in BFMI mice is a strategy of the organism
to counteract the rise of obesity rather than promoting
the formation of the obese phenotype. However, the sig-
nalling from Ppar genes to the fatty acid oxidation
s e e m st ob ed i s t u r b e d .I nr e s p o n s et oH F D ,l i k e w i s e
mechanisms seem to be activated that hamper fat gain.
In HFD-fed BFMI mice, the fatty acid oxidation, keto-
genesis and thermogenesis are up-regulated indicating
increased utilization of fatty acids as energy source.
Despite increased fatty acid oxidations, elevated lipogen-
esis led to additional fat stored in the adipose tissue and
fatty liver in HFD-fed BFMI mice.
Considering the many differences in PPAR gene
expression in comparison to B6 mice and in the
response to HFD, BFMI mice provide a new model for
the study of PPAR actions under controlled genetic and
environmental conditions.
Methods
Animals and diets
In this study, we used males of the BFMI860 line which
was generated from an outbred population. Founders of
the BFMI line were originally purchased from pet shops
and were consecutively selected for low protein content,
low body mass and high fat content, and for high fat-
ness for 58 generations before inbreeding [9]. C57BL/
6NCrl (B6) mice (Charles River Laboratories, Sulzfeld,
Germany) were used as a control because this mouse
line was a parental line for a cross-bred experiment to
map genetic loci affecting body fat content in BFMI
mice [11]. Mice were kept at room temperature (22°C -
24°C) with a light dark cycle of 12 hours. After weaning
at the age of three weeks, 11 mice of the BFMI line and
15 mice of the B6 line were randomly chosen and fed a
standard maintenance diet (SMD) containing 12.8 MJ/
kg metabolizable energy with 9% of its energy from fat,
3 3 %f r o mp r o t e i nc o n t e n ta nd 58% from carbohydrates
(V1534-000 ssniff R/M-H, ssniff Spezialdiäten GmbH,
Soest, Germany). Twelve additional males of the BFMI
line were set on a high-fat diet (HFD) containing 19.1
MJ/kg metabolizable energy with 45% of its energy from
fat, 24% from protein content and 31% from
carbohydrates (S8074-E010 ssniff EF R/M, ssniff Spezial-
diäten GmbH, Soest, Germany). The ingredients of both
diets are given in Table 3. The standard diet derived its
fat from soy oil, whereas the high-fat diet derived its fat
from coconut oil and suet. Animals had ad libitum
access to water and diets. All animal treatments were in
accordance with the German Animal Welfare Legisla-
tion (approval no. G0152/04).
Phenotypes
For the phenotypic characterization, animals were
weighed weekly on the basis of their day of birth from
the age of 3 weeks on. Body fat mass and body lean
mass were also determined weekly in non-anesthetized
animals by quantitative magnetic resonance (QMR) ana-
lysis using the EchoMRI whole body composition analy-
zer (Echo Medical Systems, Houston, Texas, USA) [21].
At 10 weeks, mice were fasted for two hours, anesthe-
tized with isofluran and immediately killed by decapita-
tion. After bleeding, different white adipose tissues
(reproductive, renal, subcutaneous) and liver were dis-
sected and weighed. The remaining white adipose tis-
sues were collected and weighted. The sum of all visible
white adipose tissues was termed ‘total white fat tissue’.
Histology
For the histological examinations, the reproductive adi-
pose tissue (around the testicles), the retroperitoneal (as
part of the renal adipose tissue), the inguinal adipose tis-
sue (as part of the subcutaneous adipose tissue) and the
liver of three animals of each line and diet group were
immediately fixed upon dissection in 4% buffered for-
maldehyde solution (pH 7.4) for 24 hours. Adipose
Table 3 Ingredients of standard maintenance diet (SMD)
and high-fat diet (HFD)
Ingredient SMD HFD
Crude nutrients proportion [%]
Crude proteins 19.0 20.7
Crude fat 3.3 25.0
Crude fiber 4.9 5.0
Crude ashes 6.7 5.9
Dry substance 87.7 96.3
N-free extracts 54.1 39.7
Starch 36.5 20.0
Sugar 4.7 17.5
Metabolizable energy MJ/kg
12.8 19.1
% of energy
Fat 9.0 45.0
Carbohydrate 58.0 31.0
Protein 33.0 24.0
Both diets contained also vitamins, trace elements, and minerals.
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Page 8 of 10tissue samples were embedded in paraffin following
standard laboratory procedures. Sections (3 μm) of
dewaxed tissues were stained with hematoxylin and
eosin. Adipocyte cell diameter was measured from 30
cells per tissue per mouse. Cells with a round shape
were chosen for determination of the cell size. Cryosec-
tions (10 μm) of liver tissue were incubated with 0.18%
oil-red O for 10 min, washed with 60% isopropanol, and
counterstained with hematoxylin. Sections were photo-
graphed at 100x magnification with a digital camera.
Serum parameters
B l o o dw a sc o l l e c t e da ts l a u g h t e r i n ga n ds e r u mw a s
recovered by centrifugation for 15 min at 600 g and
stored at -20°C until analysis. Serum triglycerides and
total cholesterol were determined using the Fluitest TG
(Triglyceride GPO-PAP) and Fluitest Chol (Cholesterin
CHOD-PAP) kits (both Biocon Medizintechnik, Mön-
chberg, Germany).
RNA isolation and microarray analysis
For gene expression analyses, the reproductive adipose
tissue and liver of six mice per feeding group at ten
weeks were immediately frozen in liquid nitrogen. We
used the reproductive adipose tissue for gene expression
analysis as visceral white adipose tissue is known to be
more metabolically active than subcutaneous [18,22].
Total RNA was prepared using the NucleoSpin RNA II
Kit (Macherey-Nagel, Düren, Germany) following the
manufacturer’s protocol. Quality of RNA was verified on
an agarose gel with ethidium bromide staining. 400 ng
of RNA was reverse transcribed to synthesize first and
second strand complementary DNA (cDNA), purified
with spin columns and then in vitro transcribed to
synthesize biotin-labelled complementary RNA (cRNA)
(Ambion Illumina RNA Amplification Kit, Cambridge-
shire, UK). 1.5 μg biotin-labeled cRNA was hybridized
onto Mouse-6 v1 Expression BeadChips (Illumina Inc,
San Diego, CA, USA), representing >46,000 probe
sequences per array, for 16 hours at 55°C. BeadChips
were then scanned using Illumina’s BeadStation 500X
gene expression system (Illumina Inc., San Diego, CA).
Fluorescence images of the Illumina BeadArrays were
translated into relative expression levels using the Bio-
conductor [23] package beadarray [24] with standard
parameter settings. The intensity values of the arrays
were log2-transformed and quantile-normalized for each
tissue separately.
Analyses of expression data
ANOVA was performed to evaluate differences between
( i )t h eB F M Ia n dB 6m i c eo nS M Da n d( i i )b e t w e e n
BFMI mice on SMD and HFD using the SAS 9.1 statisti-
cal software package (SAS Institute Inc., Cary, NC,
USA). For body composition and serum parameters, the
Wilcoxon rank sum test was used and for the compari-
son of the adipocyte diameters, t-tests for two group
comparisons were used. P-values smaller than 0.05 were
considered statistically significant. For the comparison
of time courses for weight and fat gain, longitudinal
data were subjected to ANOVA with repeated
measurement.
To measure the significance of differential expression
two separate t-tests were performed for each oligo in
each tissue: BFMI on SMD vs. B6 on SMD and BFMI
on HFD vs. BFMI on SMD. To address multiple testing,
local false discovery rates (local FDR) were calculated.
For this purpose a customized algorithm following
Aubert et al. [25] was implemented in R. Differentially
expressed genes which had both p-values smaller than
0.05 and local FDRs smaller than 0.5 were considered
statistically significant. Where necessary, medians of
fold-changes and medians of significance values (p-value
and local FDR) were used to define unique values for
each gene if multiple oligos were present on the chip
that measured the expression of the same gene. Genes
showing significant differences between groups were
assigned to the PPAR pathway based on the Kyoto
Encyclopedia of Genes and Genomes (KEGG) database
[26]. Pathways were visualized with GenMAPP [27].
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